p21(WAF1/CIP1) protein expression, p53 protein accumulation and tumor proliferation in bone marrow metastases of prostate carcinoma

被引:0
|
作者
Troncoso, P [1 ]
Navone, N [1 ]
Pisters, L [1 ]
Ordonez, N [1 ]
vonEschenbach, AC [1 ]
Logothetis, C [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,HOUSTON,TX
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:487 / 487
页数:1
相关论文
共 50 条
  • [1] p21(Waf1/Cip1) and p53 protein expression in breast cancer
    Wakasugi, E
    Kobayashi, T
    Tamaki, Y
    Ito, Y
    Miyashiro, I
    Komoike, Y
    Takeda, T
    Shin, E
    Takatsuka, Y
    Kikkawa, N
    Monden, T
    Monden, M
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (06) : 684 - 691
  • [2] THE EXPRESSION AND SIGNIFICANCE OF P53 AND P21(WAF1/CIP1) IN THYROID CARCINOMA
    霍雄伟
    马清涌
    高燕凤
    孙学军
    刘浩
    盛薇
    [J]. Journal of Pharmaceutical Analysis, 2005, (01) : 86 - 89
  • [3] p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma
    Schmider, A
    Gee, C
    Friedmann, W
    Lukas, JJ
    Press, MF
    Lichtenegger, W
    Reles, A
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 77 (02) : 237 - 242
  • [4] Expression of p21(WAF1/CIP1) in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression
    Yasui, W
    Akama, Y
    Yokozaki, H
    Semba, S
    Kudo, Y
    Shimamoto, F
    Tahara, E
    [J]. PATHOLOGY INTERNATIONAL, 1997, 47 (07) : 470 - 477
  • [5] p53/p21((waf1/cip1)) expression in human lung cancer
    Bennett, WP
    ElDeiry, WS
    Guinee, DG
    Caporaso, NE
    Welsh, JA
    Jones, RT
    Borkowski, A
    Travis, WD
    Colby, TV
    Trastek, V
    Pairolero, PC
    Tazelaar, HF
    Midthun, D
    Jett, JR
    Liotta, LA
    Vogelstein, B
    Harris, CC
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 895 - 895
  • [6] p21(Waf1/cip1) expression
    Rees, JL
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (05) : 803 - 803
  • [7] Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas
    Shi Y.-Z.
    Hui A.-M.
    Takayama T.
    Li X.
    Cui X.
    Makuuchi M.
    [J]. British Journal of Cancer, 2000, 83 (1) : 50 - 55
  • [8] Bcl-2, p21 (WAF1/CIP1) and p53 in pancreatic carcinoma
    Bruecks, A
    Saxena, A
    [J]. FASEB JOURNAL, 1998, 12 (04): : A196 - A196
  • [9] Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas
    Hui, AM
    Kanai, Y
    Sakamoto, M
    Tsuda, H
    Hirohashi, S
    [J]. HEPATOLOGY, 1997, 25 (03) : 575 - 579
  • [10] p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer
    Kuwahara, M
    Hirai, T
    Yoshida, K
    Yamashita, Y
    Hihara, J
    Inoue, H
    Toge, T
    [J]. DISEASES OF THE ESOPHAGUS, 1999, 12 (02) : 116 - 119